Results
Title

First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies.

Authors

Berlin, Jordan; Tolcher, Anthony W.; Ding, Cliff; Whisenant, Jennifer G.; Horak, Ivan D.; Wood, Debra L.; Nadler, Paul I.; Hansen, Ulla Holm; Lantto, Johan; Skartved, Niels Jørgen Ø.; Pedersen, Mikkel W.; Patnaik, Amita

Publication

Investigational New Drugs, 2022, Vol 40, Issue 3, p586

ISSN

0167-6997

Publication type

Academic Journal

DOI

10.1007/s10637-022-01217-7